BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 9393873)

  • 1. JNK1, JNK2 and JNK3 are p53 N-terminal serine 34 kinases.
    Hu MC; Qiu WR; Wang YP
    Oncogene; 1997 Nov; 15(19):2277-87. PubMed ID: 9393873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of MAP kinases in UVB-induced phosphorylation of p53 at serine 20.
    She QB; Ma WY; Dong Z
    Oncogene; 2002 Feb; 21(10):1580-9. PubMed ID: 11896587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role for c-Jun N-terminal kinase 1 (JNK1), but not JNK2, in the beta-amyloid-mediated stabilization of protein p53 and induction of the apoptotic cascade in cultured cortical neurons.
    Fogarty MP; Downer EJ; Campbell V
    Biochem J; 2003 May; 371(Pt 3):789-98. PubMed ID: 12534344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoenzyme-specific protein kinase C and c-Jun N-terminal kinase activation by electrically stimulated contraction of neonatal rat ventricular myocytes.
    Strait JB; Samarel AM
    J Mol Cell Cardiol; 2000 Aug; 32(8):1553-66. PubMed ID: 10900180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperation between JNK1 and JNK2 in activation of p53 apoptotic pathway.
    Oleinik NV; Krupenko NI; Krupenko SA
    Oncogene; 2007 Nov; 26(51):7222-30. PubMed ID: 17525747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of c-Jun NH2-terminal kinases by interleukin-1 beta in normal human osteoblastic and rat UMR-106 cells.
    Chaudhary LR; Avioli LV
    J Cell Biochem; 1998 Apr; 69(1):87-93. PubMed ID: 9513050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosine phosphorylation of Vav stimulates IL-6 production in mast cells by a Rac/c-Jun N-terminal kinase-dependent pathway.
    Song JS; Haleem-Smith H; Arudchandran R; Gomez J; Scott PM; Mill JF; Tan TH; Rivera J
    J Immunol; 1999 Jul; 163(2):802-10. PubMed ID: 10395673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 mediates bcl-2 phosphorylation and apoptosis via activation of the Cdc42/JNK1 pathway.
    Thomas A; Giesler T; White E
    Oncogene; 2000 Nov; 19(46):5259-69. PubMed ID: 11077443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-JUN N-terminal kinase-1 (JNK1) but not JNK2 or JNK3 is involved in UV signal transduction in human epidermis.
    Katagiri C; Negishi K; Hibino T
    J Dermatol Sci; 2006 Sep; 43(3):171-9. PubMed ID: 16824735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
    Gulati AP; Yang YM; Harter D; Mukhopadhyay A; Aggarwal BB; Benzil DL; Whysner J; Albino AP; Murali R; Jhanwar-Uniyal M
    Mol Carcinog; 2006 Jan; 45(1):26-37. PubMed ID: 16267831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic induces apoptosis through a c-Jun NH2-terminal kinase-dependent, p53-independent pathway.
    Huang C; Ma WY; Li J; Dong Z
    Cancer Res; 1999 Jul; 59(13):3053-8. PubMed ID: 10397243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiency of c-Jun-NH(2)-terminal kinase-1 in mice enhances skin tumor development by 12-O-tetradecanoylphorbol-13-acetate.
    She QB; Chen N; Bode AM; Flavell RA; Dong Z
    Cancer Res; 2002 Mar; 62(5):1343-8. PubMed ID: 11888903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of protein kinase activities associated with p53-large-T immune complexes from SV40-transformed rat cells.
    Müller E; Boldyreff B; Scheidtmann KH
    Oncogene; 1993 Aug; 8(8):2193-205. PubMed ID: 8393163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential phosphorylations of Spi-B and Spi-1 transcription factors.
    Mao C; Ray-Gallet D; Tavitian A; Moreau-Gachelin F
    Oncogene; 1996 Feb; 12(4):863-73. PubMed ID: 8632909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JSAP1, a novel jun N-terminal protein kinase (JNK)-binding protein that functions as a Scaffold factor in the JNK signaling pathway.
    Ito M; Yoshioka K; Akechi M; Yamashita S; Takamatsu N; Sugiyama K; Hibi M; Nakabeppu Y; Shiba T; Yamamoto KI
    Mol Cell Biol; 1999 Nov; 19(11):7539-48. PubMed ID: 10523642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and characterization of a protein kinase which is activated by SV40 large T-antigen and phosphorylates the tumor suppressor protein p53.
    Müller E; Scheidtmann KH
    Oncogene; 1995 Mar; 10(6):1175-85. PubMed ID: 7700642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human c-Jun N-terminal kinase expression and activation in the nervous system.
    Kumagae Y; Zhang Y; Kim OJ; Miller CA
    Brain Res Mol Brain Res; 1999 Apr; 67(1):10-7. PubMed ID: 10101227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel system to investigate the phosphorylation of the p53 tumor suppressor protein by the protein kinase CK2.
    McKendrick L; Meek DW
    Cell Mol Biol Res; 1994; 40(5-6):555-61. PubMed ID: 7735330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of microtubule-associated protein tau by isoforms of c-Jun N-terminal kinase (JNK).
    Yoshida H; Hastie CJ; McLauchlan H; Cohen P; Goedert M
    J Neurochem; 2004 Jul; 90(2):352-8. PubMed ID: 15228592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 is phosphorylated in vitro and in vivo by the delta and epsilon isoforms of casein kinase 1 and enhances the level of casein kinase 1 delta in response to topoisomerase-directed drugs.
    Knippschild U; Milne DM; Campbell LE; DeMaggio AJ; Christenson E; Hoekstra MF; Meek DW
    Oncogene; 1997 Oct; 15(14):1727-36. PubMed ID: 9349507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.